Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	30150
Country	Australia

Received	2016-09-14 15:58
Peer-Review Started	2016-09-18 18:28
To Make the First Decision	2016-10-21 08:57
Return for Revision	2016-10-21 12:13
Revised	2016-10-25 00:00
Second Decision	2016-11-10 14:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-11-22 15:10
Articles in Press	2016-11-22 15:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-28 20:33
Publish the Manuscript Online	2017-01-12 12:07

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Omar Elaskalani, Norbaini Binti Abdol Razak, Marco Falasca and Pat Metharom
Funding Agency and Grant Number
Corresponding Author	Marco Falasca, PhD, Professor, Head of Metabolic Signalling Group, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Kent Street, Bentley, Perth, Western Australia 6102, Australia. marco.falasca@curtin.edu.au
Key Words	Epithelial-mesenchymal transition; Drug resistance; Pancreatic cancer; Chemotherapy
Core Tip	This mini-review examines the role of epi-thelial-mesenchymal transition in the development of drug resistant pancreatic cancer and a possible use of this process as a drug target.
Publish Date	2017-01-12 12:07
Citation	Elaskalani O, Razak NBA, Falasca M, Metharom P. Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. World J Gastrointest Oncol 2017; 9(1): 37-41
URL	http://www.wjgnet.com/1948-5204/full/v9/i1/37.htm
DOI	http://dx.doi.org/10.4251/wjgo.v9.i1.37

Full Article (PDF)	WJGO-9-37.pdf
Full Article (Word)	WJGO-9-37.doc
Manuscript File	30150-Review.docx
Answering Reviewers	30150-Answering reviewers.pdf
Audio Core Tip	30150-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	30150-Conflict-of-interest statement.pdf
Copyright License Agreement	30150-Copyright assignment.pdf
Peer-review Report	30150-Peer-review(s).pdf
Scientific Misconduct Check	30150-Scientific misconduct check.pdf
Scientific Editor Work List	30150-Scientific editor work list.pdf